D. Merante

发表

A. Ceriello, D. Merante, 2011, Pharmaceutical Medicine.

Developing New Molecules for the Treatment of Painful Diabetic Peripheral Neuropathy: Is it Feasible given the Magnitude of the Placebo Response in Proof of Concept Clinical Studies?

R. Malik, G. Skouteris, D. Merante, 2013 .

A comparison of preconstituted, fixed combinations of low-dose glyburide plus metformin versus high-dose glyburide alone in the treatment of type 2 diabetic patients

P. Marchetti, D. Merante, A. Coppini, 1999, Acta Diabetologica.

Retrospective Analysis of Rosiglitazone and Macular Oedema in Patients with Type 2 Diabetes Mellitus

P. Tatti, D. Merante, F. Costanza, 2008, Clinical drug investigation.

Effects of Gliquidone and Glibenclamide on Metabolic Response and Insulin Receptor Interaction in Monocytes from Patients with Type 2 Diabetes Mellitus

A. Ciccarone, P. Cecchetti, R. Navalesi, 1999 .

A 26-week, placebo- and pioglitazone-controlled, dose-ranging study of rivoglitazone, a novel thiazolidinedione for the treatment of type 2 diabetes

J. Rosenstock, R. Goldberg, K. Truitt, 2010, Current medical research and opinion.

Rosiglitazone cools down inflammation in the metabolic syndrome.

D. Giugliano, K. Esposito, M. Ciotola, 2006, Arteriosclerosis, thrombosis, and vascular biology.

Beneficial role of l‐arginine in cardiac matrix remodelling in insulin resistant rats

L. Monti, P. Piatti, S. Costa, 2008, European journal of clinical investigation.

Importance of premeal injection time in insulin therapy: Humalog Mix25 is convenient for improved post-prandial glycemic control in type 2 diabetic patients with Italian dietary habits

M. Gobbo, F. Leonetti, A. Galluzzo, 2003, Acta Diabetologica.

HLA DR/DQ alleles and risk of type I diabetes in childhood: a population–based case–control study

S. Tiberti, A. Verrotti, S. Tumini, 2005, Clinical and Experimental Medicine.

Impact of the Nocebo Effect in Clinical Studies of Painful Diabetic Peripheral Neuropathy and Potential Strategies to Minimize this Effect

D. Merante, A. Currie, K. Feins, 2013 .

Compassionate Use of Cefiderocol as Adjunctive Treatment of Native Aortic Valve Endocarditis Due to Extremely Drug-resistant Pseudomonas aeruginosa

Andrew Jones, R. Beale, D. Livermore, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Diabetic Macular Edema

Francesca Menchini, F. Menchini, F. Bandello, 2010, Drug safety.

(403) Co-administration of mirogabalin and zolpidem in healthy subjects: results from a randomized, double-blind, drug-drug interaction study.

H. Zahir, D. Merante, K. Brown, 2016, The journal of pain : official journal of the American Pain Society.

The mirogabalin ALDAY phase 3 program in pain associated with fibromyalgia: the lessons learned

D. Merante, 2020, Current medical research and opinion.

Efficacy and Safety of Mirogabalin (DS-5565) for the Treatment of Diabetic Peripheral Neuropathic Pain: A Randomized, Double-Blind, Placebo- and Active Comparator–Controlled, Adaptive Proof-of-Concept Phase 2 Study

J. Rosenstock, A. Vinik, D. Merante, 2014, Diabetes Care.

[Effectiveness and tolerability of oral liquid ferrous gluconate in iron-deficiency anemia in pregnancy and in the immediate post-partum period: comparison with other liquid or solid formulations containing bivalent or trivalent iron].

P. Del Carlo, D. Merante, A. Grossi, 1996, Minerva ginecologica.

A 26‐week, placebo‐ and pioglitazone‐controlled monotherapy study of rivoglitazone in subjects with type 2 diabetes mellitus

Y. Mun, J. Moberly, K. Truitt, 2012, Diabetes, obesity & metabolism.

Efficacy and safety of mirogabalin for the treatment of fibromyalgia: results from three 13-week randomized, double-blind, placebo- and active-controlled, parallel-group studies and a 52-week open-label extension study

L. Arnold, D. Merante, D. Jacobs, 2019, Current medical research and opinion.

Population pharmacokinetic modeling and simulation for assessing renal impairment effect on the pharmacokinetics of mirogabalin

Raymond Miller, O. Yin, K. Truitt, 2016, Journal of clinical pharmacology.

SARS-CoV-2, from its current highly contagious spreading toward the global development of an effective and safe vaccine: challenges and uncertainties

D. Merante, 2020, Expert opinion on drug safety.

Efficacy of Mirogabalin (DS-5565) on Patient-Reported Pain and Sleep Interference in Patients with Diabetic Neuropathic Pain: Secondary Outcomes of a Phase II Proof-of-Concept Study

J. Rosenstock, A. Vinik, D. Merante, 2017, Pain medicine.

Effect of rosiglitazone on endothelial function and inflammatory markers in patients with the metabolic syndrome.

D. Giugliano, K. Esposito, F. Saccomanno, 2006, Diabetes care.

Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Mirogabalin When Coadministered With Lorazepam, Zolpidem, Tramadol, or Ethanol: Results From Drug‐Drug Interaction Studies in Healthy Subjects

H. Zahir, J. Mendell, Ling He, 2018, Clinical pharmacology in drug development.

An Assessment of Clinically Important Differences on the Worst Pain Severity Item of the Modified Brief Pain Inventory in Patients with Diabetic Peripheral Neuropathic Pain

D. Merante, Mei Yang, Ching Hsu, 2018, Pain research & management.

Compassionate use of cefiderocol as adjunctive treatment of native aortic valve endocarditis due to XDR-Pseudomonas aeruginosa

Andrew Jones, R. Beale, D. Livermore, 2019 .